Senescent mesenchymal stem cells stimulate proliferation and migration of breast cancer cells in vitro and promote tumor progression in xenograft mice by activating IL-6/STAT-3 signaling pathway (Di et al., 2014; Zacarias-Fluck et al., 2015; Liu et al., 2017). This evidence concerns the gene IL6 and breast cancer.